Research

#Collaboration #Genomics #Genomics England #NHS #Public health #Research #Revvity

Collaboration to advance UK genomics research 

Revvity has announced an expansion of its working relationship with Genomics England that leverages both organisations’ expertise and resources to advance critical genomic initiatives across the United Kingdom.   Building on the parties’ long and productive work history, this collaboration is dedicated to accelerating Genomics England’s research programmes,… Read More

#Business & Investment #News

Drug discovery innovation
#Drug discovery #ELRIG #Events #Medicines Discovery Catapult #Research

Keynotes announced for Research and Innovation 2024

The European Laboratory Research & Innovation Group (ELRIG) UK has announced the keynote speakers for its upcoming Research & Innovation conference: Steve Bates OBE FMedSci, CEO, BioIndustry Association (BIA) and Dr Anderson Ryan, Co-founder and Head of R&D and Drug Development, FasT BioPharma.   The event, taking place… Read More

#News

AIDS
#AIDs #American Association of Pharmaceutical Scientists #Cambridge Crystallographic Data Centre #Collaboration #Pharmaceuticals #Research

CCDC AIDS research wins AAPS pharma award 

A Cambridge Crystallographic Data Centre (CCDC) research paper has won an Outstanding Manuscript Award from the American Association of Pharmaceutical Scientists (AAPS).  The research paper, Solid-State and Surface Structures of the Conformational Polymorphic Forms of Ritonavir in Relation to their Physicochemical Properties, published in the… Read More

#News

#Contract Research Organisations (CROs) #Digitalisation #Proscia #Research #Therapeutics

Key findings from life sciences digital pathology adoption survey 

Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia. Over half of these organisations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of… Read More

#Editor's Choice #News

#Drug discovery #Research #Research and development

Scientific SaaS platform to accelerate drug and materials development 

Revvity has launched its Signals Research Suite, a unified, cloud-native SaaS platform that drives scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development.   The new solution from Revvity Signals Software, the software and informatics arm of Revvity, is available worldwide. It integrates the… Read More

#News

Science and research of the universe; quantum science
#Collaboration #Deep learning #Deep tech #Life sciences #Quantum computing #Research

Start-up accelerator to unlock potential in quantum science 

BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating life science research, has launched a new deep tech accelerator start-up programme, the Deep Tech Lab – Quantum, to propel emergent and disruptive quantum science and biotechnology solutions toward the marketplace.   Deep tech and quantum science have… Read More

#News

#Lab automation #NGS #Research

Competition: Win a MagicPrep NGS instrument with Tecan

Are you pushing the boundaries of what’s possible with NGS? Are you conducting cutting-edge research that’s driving real-world benefits? Could your lab use an extra pair of hands? Then submit an abstract today for your chance to win a MagicPrep NGS instrument* and enjoy NGS library preparation at the push… Read More

#News

#AI #Antimicrobial resistance (AMR) #Bioscience #Drug development #Europe #Phage therapy #Research

Grant will allow development of phage therapy diagnostic platform 

Vésale Bioscience, a company in the research and development of solutions and treatments using phage therapy for multi-resistant infections, has received €1.8 million in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project.  The project is a phagogram using artificial intelligence (AI) that… Read More

#News

#Assays #Biotechnology #DNA #Next generation sequencing #Research

Key acquisition for next generation sequencing research assays

Integrated DNA Technologies has purchased next generation sequencing (NGS) research assays from Invitae Corporation under the trademarked name Archer.   The integration of IDT’s portfolio with the acquired NGS research assays—which have been foundational in researching novel cancer fusions—will empower labs with a solution to uncover biomarkers and… Read More

#News

#AstraZeneca #Biobanking #Covid-19 #Genetics #Genomics #Public health #Research

Podcast: Is genomic data the new frontier in drug discovery?

This is the latest episode of the free narrated DDW podcast, “Is genomic data the new frontier in drug discovery?” It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “Genomics boosts understanding of Covid-19 severity and susceptibility” and “… Read More

#News

Genomics
#Biotechnology #Comment #Data #Gene editing #Genetics / genomics #Genome sequencing #Healthcare #Public health #Research #Whole genome sequencing

Why genomic healthcare data matters in the development of new therapies 

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact.  The origins  One might… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Biopharmaceuticals #Drug development #Liquid handling #Research

LC-MS Analysis for (Bio)pharmaceutical Research

In the seventh eBook of the Hamilton series “LC-MS Analysis for (Bio)pharmaceutical Research”, we discuss: The role of LC-MS in the drug development process The drivers behind the need for LC-MS sample prep automation in biopharma The modules and full liquid handling automation solutions that Hamilton offers for LC-MS… Read More

#Intelligence #Resources

#Comment #ELRIG #Genomics #Innovation #Research

Comment: Innovations for tomorrow’s drug discovery 

At the end of last month, DDW’s Megan Thomas attended ELRIG’s Research & Innovation 2022: Innovations for Tomorrow’s Drug Discovery, at The King’s Centre in Oxford, UK. The four sessions addressed aspects of innovation across drug discovery and placed an emphasis on both the digital age and novel modalities:… Read More

#Exclusive Content #News #Opinion

#Analysis #Clinical trials #Data #Research #Ukraine

How war in Ukraine impacts global clinical development 

New global data analysis from Phesi shows the extent of the impact from the war in Ukraine on clinical development.   Phesi analysed pivotal trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities.   The findings  The findings show that… Read More

#News #Trending News